| Gamma-secretase activating protein is a therapeutic target for Alzheimer’s disease G He, W Luo, P Li, C Remmers, WJ Netzer, J Hendrick, K Bettayeb, ... Nature 467 (7311), 95-98, 2010 | 407 | 2010 |
| Identification of protease 3.4. 24.11 as the major atrial natriuretic factor degrading enzyme in the rat kidney JL Sonnenberg, Y Sakane, AY Jeng, JA Koehn, JA Ansell, LP Wennogle, ... Peptides 9 (1), 173-180, 1988 | 218 | 1988 |
| Human brain receptor alterations in suicide victims LR Meyerson, LP Wennogle, MS Abel, J Coupet, AS Lippa, CE Rauh, ... Pharmacology Biochemistry and Behavior 17 (1), 159-163, 1982 | 215 | 1982 |
| Transmembrane Orientation of Proteins Present in Acetylcholine Receptor‐Rich Membranes from Torpedo marmorata Studied by Selective Proteolysis LP Wennogle, JP CHANGEUX European Journal of Biochemistry 106 (2), 381-393, 1980 | 142 | 1980 |
| Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission GL Snyder, KE Vanover, H Zhu, DB Miller, JP O’Callaghan, J Tomesch, ... Psychopharmacology 232, 605-621, 2015 | 133 | 2015 |
| Serotonin modulates the dissociation of [3H] imipramine from human platelet recognition sites LP Wennogle, LR Meyerson European journal of pharmacology 86 (2), 303-307, 1982 | 130 | 1982 |
| CGS 9343B, a novel, potent, and selective inhibitor of calmodulin activity. JA Norman, J Ansell, GA Stone, LP Wennogle, JW Wasley Molecular pharmacology 31 (5), 535-540, 1987 | 124 | 1987 |
| Conditions for the selective labelling of the 66 000 dalton chain of the acetylcholine receptor by the covalent non-competitive blocker 5-azido-[3H]trimethisoquin T Saitoh, R Oswald, LP Wennogle, JP Changeux FEBS letters 116 (1), 30-36, 1980 | 121 | 1980 |
| Allosteric Interaction Between the Site Labeled by [3H]Imipramine and the Serotonin Transporter in Human Platelets LR Meyerson, JR Ieni, LP Wennogle Journal of neurochemistry 48 (2), 560-565, 1987 | 109 | 1987 |
| Organic compounds P Li, J Zhao, H Zheng, L Wennogle US Patent 8,664,207, 2014 | 108 | 2014 |
| Organic compounds P Li, J Zhao, H Zeng, L Wennogle US Patent 8,536,159, 2013 | 107 | 2013 |
| Organic compounds P Li, J Zhao, H Zeng, L Wennogle US Patent 8,633,180, 2014 | 105 | 2014 |
| Organic compounds P Li, J Zhao, H Zheng, LP Wennogle US Patent App. 13/133,096, 2011 | 100 | 2011 |
| Discovery of a tetracyclic quinoxaline derivative as a potent and orally active multifunctional drug candidate for the treatment of neuropsychiatric and neurological disorders P Li, Q Zhang, AJ Robichaud, T Lee, J Tomesch, W Yao, JD Beard, ... Journal of Medicinal Chemistry 57 (6), 2670-2682, 2014 | 97 | 2014 |
| Isoform-specific localization of A-RAF in mitochondria A Yuryev, M Ono, SA Goff, F Macaluso, LP Wennogle Molecular and cellular biology, 2000 | 96 | 2000 |
| Structural definition of the C5a C terminus by two‐dimensional nuclear magnetic resonance spectroscopy X Zhang, W Boyar, MJ Toth, L Wennogle, NC Gonnella Proteins: Structure, Function, and Bioinformatics 28 (2), 261-267, 1997 | 95 | 1997 |
| Organic compounds P Li, H Zheng, J Zhao, LP Wennogle US Patent 9,556,185, 2017 | 93 | 2017 |
| Organic compounds P Li, J Zhao, H Zheng, LP Wennogle US Patent App. 13/133,147, 2012 | 90 | 2012 |
| Optionally substituted 3-amino-4-(thioxo or imino)-4, 5-dihydro-2H-pyrazolo [3, 4-d] pyrimidin-6 (7H)-ones P Li, J Zhao, H Zeng, L Wennogle US Patent 8,697,710, 2014 | 89 | 2014 |
| Organic compounds P Li, H Zheng, J Zhao, LP Wennogle US Patent 10,561,656, 2020 | 85 | 2020 |
